Order Entry
United States
ContactUsLinkComponent
Homoarginine ELISA Assay Kit, Eagle Biosciences, Inc.
Homoarginine ELISA Assay Kit, Eagle Biosciences, Inc.
  102994-464
 :  
Homoarginine ELISA Assay Kit, Eagle Biosciences, Inc.
  102994-464
 :  EA205/96
 :  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.

 

  • Host:
  • Primary antibody reactivity:
  • Description:
    Homoarginine ELISA Assay Kit
  • Size:
    1 kit
  • Environmentally Preferable:
  • Cat. No.:
    102994-464
  • Supplier no.:
    HOM39-K01

 

 

Homoarginine ELISA detects homoarginine in serum, plasma, or cell culture samples.

  • Dynamic Range: 0.3 - 7.0 µmol/L
  • Sensitivity: 0.05 µmol/L
  • Incubation: 2.5 hours

Homoarginine is a non-essential cationic amino acid, which is formed from lysine.  In vitro and in vivo, homoarginine shows characteristics similar to arginine. Epidemiological investigations in two large independent cohorts, namely the German diabetes dialysis (4D) study and the Ludwigshafen Risk and Cardiovascular Health (LURIC) study have identified homoarginine as useful predictor of cardiovascular events and mortality.